EDGAR Filing Documents for 0001193125-20-323829

Form SC TO-T - Tender offer statement by Third Party:

SEC Accession No. 0001193125-20-323829

Filing Date

2020-12-22

Accepted

2020-12-22 07:07:44

Documents

Group Members

TYTO ACQUISITION CORP

Document Format Files

Seq	Description	Document	Type	Size
1	SC TO-T	d79901dsctot.htm	SC TO-T	77870
2	EX-99.(A)(1)(A)	d79901dex99a1a.htm	EX-99.(A)(1)(A)	521812
3	EX-99.(A)(1)(B)	d79901dex99a1b.htm	EX-99.(A)(1)(B)	214177
4	EX-99.(A)(1)(C)	d79901dex99a1c.htm	EX-99.(A)(1)(C)	12685
5	EX-99.(A)(1)(D)	d79901dex99a1d.htm	EX-99.(A)(1)(D)	21229
6	EX-99.(A)(1)(E)	d79901dex99a1e.htm	EX-99.(A)(1)(E)	27920
7	EX-99.(D)(6)	d79901dex99d6.htm	EX-99.(D)(6)	28388
8	GRAPHIC	g79901g11a01.jpg	GRAPHIC	28241
9	GRAPHIC	g79901g76u52.jpg	GRAPHIC	51613
10	GRAPHIC	g79901g78a02.jpg	GRAPHIC	27408
11	GRAPHIC	g79901g99a01.jpg	GRAPHIC	28724
	Complete submission text file	0001193125-20-323829.txt		1082004

Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285

Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC TO-T
SIC: 2834 Pharmaceutical Preparations

Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016

Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310

Prevail Therapeutics Inc. (Subject) CIK: 0001714798 (see all company filings)